Specific labeling of the active site of cytosolic aspartate aminotransferase through the use of a cofactor analogue, N-(Bromoacetyl)pyridoxamine.
Specific labeling of the active site of cytosolic aspartate aminotransferase through the use of a cofactor analogue, N-(Bromoacetyl)pyridoxamine.
复制标题
通过使用辅因子类似物 N-(溴乙酰基)吡哆胺对胞质天冬氨酸转氨酶的活性位点进行特异性标记。
DOI:
10.1021/bi00274a006
复制
发表时间:
1983
期刊:
影响因子:
2.9
通讯作者:
Martinez-Carrion,M
中科院分区:
文献类型:
--
作者:
FarachJr,HA;MattinglyJr,JR;Martinez-Carrion,M
Horacio A. Farach, Jr., Joseph R. Mattingly, Jr., and Marino Martinez-Carrion* abstract: The cofactor analogue N-(bromoacety 1) pyridoxamine (BAPM) has been employed to inactivate the cytosolic isozyme of apo-aspartate aminotransferase. Inactivation is the result of covalent bond formation in the (bromoacetyl)-pyridoxamine-transferase complex, via the e-amino group of a lysyl residue at the active site. The stoichiometry of this inactivation is one molecule of (bromoacetyl) pyridoxamine per subunit of the transaminase dimer. Trace amounts of inor-ganic phosphate protect the enzyme from BAPM inactivation. In the absence of phosphate, inactivation demonstrates time,.^^. spartate aminotransferase (EC 2.6. 1.1) is a functional dimer containing 1 mol of pyridoxal 5'-phosphate bound per subunit activesite. It catalyzes the following conversion via two half-reactions: glutamate+ Epyridoxal. 5,. P^-ketoglutarate+ Epyridoxamine. 5-. P (1)